Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b

Journal of General Virology

Volumn 80, Issue 2, 1999, Pages 317-325

  Majid, Ayaz ^a   Jackson, Peter ^b   Lawal, Zarah ^a   Pearson, Gavin M J ^b   Parker, Hayley ^a   Alexander, Graeme J M ^a   Allain, Jean Pierre ^a   Petrik, Juraj ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENETIC HETEROGENEITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; ONTOGENY; PRIORITY JOURNAL;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0033008053     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-2-317     Document Type: Article

References (47)

1. Allander, T., Beyene, A., Jacobson, S. H., Grillner, L. & Persson, M. A. A. (1997). Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response. Journal of Infectious Diseases 175, 26-31.
2. Bukh, J., Purcell, R. & Miller, R. (1993). At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proceedings of the National Academy of Sciences, USA 90, 8234-8238.
3. Colombo, M., Rumi, M. G., Donato, M. F., Tomassini, M. A., Del Ninno, E., Ronchi, G., Kuo, G. & Houghton, M. (1991). Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Digestive Diseases and Sciences 36, 1130-1133.
4. DiBisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J. & Alter, H. J. (1991). Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14, 969-974.
5. Di Marzo Veronese, F., Reitz, M. S., Jr, Gupta, G., Robert-Gouroff, M., Boyer-Thompson, C., Louie, A., Gallo, R. C. & Lusso, P. (1993). Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. Journal of Biological Chemistry 268, 25894-25901.
6. Enomoto, N., Kurosaki, M., Tanaka, Y., Marumo, F. & Sato, C. (1994). Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. Journal of General Virology 75, 1361-1369.
7. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F. & Sato, C. (1995). Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigations 96, 224-230.
8. Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J. & Purcell, R. H. (1996). Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proceedings of the National Academy of Sciences, USA 93, 15394-15399.
9. Felsenstein, J. (1989). PHYLIP: Phylogeny inference package (version 3.2). Cladistics 5, 164-166.
10. Gale, M. J., Jr, Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R. & Katze, M. G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227.
11. Higashi, Y., Kakumu, S., Yoshioka, K., Wakita, T., Mizokami, M., Ohba, K., Ito, Y., Ishikawa, T., Takayanagi, M. & Nagai, Y. (1993). Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197, 659-668.
12. Hohne, M., Schrier, E. & Roggendorf, M. (1994). Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Archives of Virology 137, 25-34.
13. Honda, M., Kaneko, S., Sakai, A., Unoura, M., Murakami, S. & Kobayashi, K. (1994). Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20, 1144-1151.
14. Jackson, P., Petrik, J., Alexander, G. J. M., Pearson, G. & Allain, J.-P. (1997). Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. Journal of Medical Virology 51, 67-79.
15. Kato, N., Sekiya, H., Ootsuyama, Y., Nakazawa, T., Hijikata, M., Ohkoshi, S. & Shimotohno, K. (1993). Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp 70) of the hepatitis C virus. Journal of Virology 67, 3923-3930.
16. Kato, N., Ootsuyama, Y., Sekiya, H., Ohkoshi, S., Nakazawa, T., Hijikata, M. & Shimotohno, K. (1994). Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. Journal of Virology 68, 4776-4784.
17. Kumar, U., Monjardino, J. & Thomas, H. C. (1994). Hypervariable region of hepatitis C virus envelope glycoprotein (E2 NS1) in an agammaglobulinemic patient. Gastroenterology 106, 1072-1075.
18. Kurosaki, M., Enomoto, N., Marumo, F. & Sato, C. (1993). Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic hepatitis. Hepatology 18, 1293-1299.
19. Lawal, Z., Petrik, J., Wong, V.-S., Alexander, G. J. M. & Allain, J.-P. (1997). Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 228, 107-111.
20. Lesniewski, R. R., Boardway, K. M., Casey, J. M., Desai, S. M., Devare, S. G., Leung, T. K. & Mushawar, I. K. (1993). Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. Journal of Medical Virology 40, 150-156.
21. Manzin, A., Solforosi, L., Petrelli, E., Maccari, G., Tosone, G., Piazza, M. & Clementi, M. (1998). Evolution of hypervariable region 1 of hepatitis C virus in primary infection. Journal of Virology 72, 6271-6276.
22. Martell, M., Esteban, J. I., Quer, J., Genesca, J., Weiner, A., Esteban, R., Guardia, J. & Gomez, J. (1992). Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of Virology 66, 3225-3229.
23. Martell, M., Esteban, J. I., Quer, J., Vargas, V., Esteban, R., Guardia, J. & Gomez, J. (1994). Dynamic behaviour of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. Journal of Virology 68, 3425-3436.
24. Naito, M., Hayashi, N., Moribe, T., Hagiwara, H., Mita, E., Kanazawa, Y., Kasahara, A., Fusamoto, H. & Kamada, T. (1995). Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 22, 407-412.
25. Nakamoto, Y., Kaneko, S., Ohno, H., Honda, M., Unoura, M., Murakami, S. & Kobayashi, K. (1996). B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis. Journal of Medical Virology 50, 35-41.
26. Nakazawa, T., Kato, N., Ootsuyama, Y., Sekiya, H., Fujioka, T., Shibuya, A. & Shimotohno, K. (1994). Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. International Journal of Cancer 56, 204-207.
27. Okada, S. I., Akahane, H., Suzuki, M., Okamoto, H. & Mishiro, S. (1992). The degree of variability in the aminoterminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16, 619-624.
28. Petrik, J., Pearson, G. M. J. & Allain, J.-P. (1997). High throughput PCR detection of HCV based on semiautomated multisample RNA capture. Journal of Virological Methods 64, 147-159.
29. Polyak, S. J., McArdle, S., Liu, S.-L., Sullivan, D. G., Chung, M., Hofgartner, W. T., Carithers, R. L., McMahon, B. J., Mullins, J. I., Corey, L. & Gretch, D. R. (1998). Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. Journal of Virology 72, 4288-4296.
30. Rosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A., Lau, J. Y. N., Choo, Q.-L., Chien, D., Pileri, P., Houghton, M. & Abrignani, S. (1996). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorometric assessment of envelope glycoprotein 2 binding to target cells. Proceedings of the National Academy of Sciences, USA 93, 1759-1763.
31. Sakamoto, N., Enomoto, N., Kurosaki, M., Marumo, F. & Sato, C. (1994). Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection. Journal of Medical Virology 42, 103-108.
32. Scarcelli, E., Cerino, A., Esposito, G., Silini, E., Mondelli, M. U. & Traboni, C. (1995). Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp 70) hypervariable region 1 in viremic hepatitis C virus-infected patients. Journal of Virology 60, 4407-4412.
33. Shimizu, Y. K., Hijikata, M., Wamoto, A., Alter, H. J., Purcell, R. H. & Yoshikura, H. (1994). Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. Journal of Virology 68, 1494-1500.
34. Shimizu, Y. K., Igarashi, H., Kiyohara, T., Cabezon, T., Farci, P., Purcell, R. H. & Yoshikura, H. (1996). A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223, 409-412.
35. Shindo, M., Hamada, K., Koya, S., Arai, K., Sokawa, Y. & Okuno, T. (1996). The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 24, 1018-1023.
36. Simmonds, P., Holmes, E. C., Cha, T.-A., Chan, S.-W., McOmish, F., Irvine, B., Beall, E., Yap, P. L., Kolberg, J. & Urdea, M. S. (1993). Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology 74, 2391-2399.
37. Sugiyama, K., Kato, N., Mizutani, T., Ikeda, M., Tanaka, T. & Shimotohno, K. (1997). Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells. Journal of General Virology 78, 329-336.
38. Swofford, D. L. (1991). PAUP: Phylogenetic analysis using parsimony (version 3.1). Distributed by the Illinois Natural History Survey, Champaign, Illinois, USA.
39. Taniguchi, S., Okamoto, H., Sakamoto, M., Kojima, M., Tsuda, F., Tanaka, T., Munekata, E., Muchmore, E. E., Peterson, D. A. & Mishiro, S. (1993). A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195, 297-301.
40. van Doom, L.-J., Quint, W., Tsiquaye, K., Voermans, J., Paelinck, D., Kos, T., Maertens, G., Schellekens, H. & Murray, K. (1994). Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. Journal of Infectious Diseases 169, 1226-1235.
41. Weiner, A. J., Brauer, M. J., Rosenblatt, J., Richman, K. H., Tung, J., Crawford, K., Bonino, F., Saracco, G., Choo, Q.-L., Houghton, M. & Han, J. H. (1991). Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180, 842-848.
42. Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., Crawford, K. A., Brunetto, M., Bar, P. J., Miyamuta, T., McHutchinson, J. & Houghton, M. (1992). Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proceedings of the National Academy of Sciences, USA 89, 3468-3472.
43. Weiner, A., Erickson, A. L., Kansopon, J., Crawford, K., Muchmore, E., Hughes, A. L., Houghton, M. & Walker, C. M. (1995). Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences, USA 92, 2755-2759.
44. Yoshioka, K., Aiyama, T., Okumura, A., Takayanagi, M., Iwata, K., Ishikawa, T., Nagai, Y. & Kakumu, S. (1997). Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a. Journal of Infectious Diseases 175, 505-510.
45. Yuki, N., Hayashi, N., Moribe, T., Matsushita, Y., Tabata, T., Inoue, T., Kanazawa, Y., Ohkawa, K., Kasahara, A., Fusamoto, H. & Kamada, T. (1997). Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 25, 439-444.
46. Zibert, A., Schreiber, E. & Roggendorf, M. (1995). Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208, 653-661.
47. Zibert, A., Kraas, W., Meisel, H., Jung, G. & Roggendorf, M. (1997). Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. Journal of Virology 71, 4123-4127.